Journal of Medical Economics, Ahead of Print. (Source: Journal of Medical Economics)
Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States
Previous post: Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults
Next post: Factors associated with willingness to take extended release naltrexone among injection drug users
